Chimerism Multiplex Plus I Kit
Elevate Transplant Outcomes with the Chimerism Multiplex Plus I Kit The Chimerism Multiplex Plus I Kit is an industry-leading diagnostic tool designed for meticulous molecular chimerism analysis post-allogenic transplantation. The kit offers simultaneous analysis of 16 INDEL markers and its flexibility extends to various sample types, including peripheral blood and bone marrow. By leveraging real-time PCR technology and specialized bioinformatics software, the kit sets a new standard in post-transplant care and medical intervention.
Quote-based, no public pricing. Add to your quote and our specialists put together a proposal with the right documentation, typically within 24 hours.
This kit in detail
Elevate Transplant Outcomes with the Chimerism Multiplex Plus I Kit
The Chimerism Multiplex Plus I Kit is an industry-leading diagnostic tool designed for meticulous molecular chimerism analysis post-allogenic transplantation. The kit offers simultaneous analysis of 16 INDEL markers and its flexibility extends to various sample types, including peripheral blood and bone marrow.
By leveraging real-time PCR technology and specialized bioinformatics software, the kit sets a new standard in post-transplant care and medical intervention.
- Real-Time PCR
- 16 INDEL Markers
- 0.01% Detection Limit
- High Specificity
Chimerism Multiplex Plus I Kit: A New Benchmark in Post-Transplant Monitoring
The Chimerism Multiplex Plus I Kit is an exemplary diagnostic tool engineered to provide unparalleled accuracy in molecular chimerism analysis following allogenic stem cell and organ transplantation.
The Chimerism Multiplex Plus I Kit employs real-time PCR technology to deliver relative quantification of a variety of molecular markers. When combined with the Multiplex Plus II, it broadens the scope to 33 markers, providing an expansive and precise dataset beneficial for informing post-transplant medical interventions. Furthermore, the kit adheres to ISO 13485:2018 quality standards, substantiating its technical reliability.
Key Features for Modern Labs
Rapid & Robust Screening
– High Throughput Analysis: Simultaneous evaluation of 16 INDELs allows for comprehensive monitoring, streamlining multiple tests into a single run.
– Universal Reference: Leverages the SRY and RhD markers as built-in controls, simplifying the overall assay and reducing errors.
Quality Assured
– ISO 13485:2018 Certification: Adheres to the stringent quality management systems, assuring you get a dependable and compliant kit.
– Built-In Reliability Checks: Incorporated positive controls and a 0.01% limit of detection ensure every test’s validity.
Versatility & Specificity
– Customizable Marker Assessment: Individualized marker selection provides a tailored approach to each transplant scenario.
– Sample Flexibility: Validated for genomic DNA from peripheral blood or bone marrow, the kit is designed for wide clinical application.
The Future is Now
In an ever-advancing medical diagnostic landscape, the Chimerism Multiplex Plus I Kit stands as a cornerstone of precision and efficiency. It transcends its role as a mere analytical tool to serve as a commitment to advancing the standard of patient care in the post-transplantation arena.
Elevate your diagnostic capabilities with the Chimerism Multiplex Plus I Kit, a strategic investment for any laboratory committed to leading-edge patient care.
The kit contians the necessary reagents to perform 10 reactions. The reagents included in the kit are the following:
- Specific Master-Mix: Specific oligonucleotides and labelled probes
Datasheets and regulatory documentation
Everything your quality team needs for evaluation and procurement.
Instructions for Use
MSDS Chimerism Multiplex Plus I Kit
Frequently paired with this kit
Other assays and instruments lab teams add alongside the Chimerism Multiplex Plus I Kit.
Add this kit to your quote
Tell us the platforms and throughput you’re planning for and our specialists will put together a clear proposal with the right documentation, no public pricing, just a considered answer.
